Default: The Lancet Infectious Diseases

ISSN: 1473-3099

Journal Home

Journal Guideline

The Lancet Infectious Diseases Q1 Unclaimed

Lancet Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The Lancet Infectious Diseases is a journal indexed in SJR in Infectious Diseases with an H index of 217. It has an SJR impact factor of 9,04 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

The Lancet Infectious Diseases

9,04

SJR Impact factor

217

H Index

517

Total Docs (Last Year)

1457

Total Docs (3 years)

9231

Total Refs

10386

Total Cites (3 years)

479

Citable Docs (3 years)

20,21

Cites/Doc (2 years)

17,85

Ref/Doc


Best articles

2017 ECIL 7 vaccine guidelines

View more

A European CDC

View more

Acute lung injury and other serious complications of Plasmodium vivax malaria

View more

African tick bite fever

View more

All for one and one for all: the true potential of whole-genome sequencing

View more

Amoebae hide a giant

View more

Antimicrobial therapy to prevent or treat oral mucositis

View more

Avascular necrosis of femoral heads in a man with HIV infection

View more

Challenges and opportunities for the management of infectious diseases in Europes' prisons: evidence-based guidance

View more

Challenges in tracking global malaria spending

View more

Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso

View more

Clinton pledges cheap antiretrovirals

View more
SHOW MORE ARTICLES

Consumers need to change attitude to antibiotic use

View more

Controversial antibiotic use for crops approved in Florida

View more

Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens

View more

De Libris

View more

Development and evaluation of influenza pandemic vaccines

View more

Development of vaccines against influenza H5

View more

Early prevention of pertussis is key

View more

Early prevention of pertussis is key -Author's reply

View more

Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines

View more

Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines -Authors' reply

View more

Emergency diagnosis and treatment of adult meningitis

View more

Epstein-Barr virus further linked to Hodgkin's lymphoma

View more

Comments

No comments ... Be the first to comment!